Herpes Labialis (Oral Cold Sores) Treatment
Covered by Aetna in California

Valacyclovir 2 g orally twice daily × 1 day (two doses, 12 hours apart) — the FDA-approved episodic regimen for herpes labialis; start at first prodrome (tingling, burning, itching) or at vesicle onset for maximum benefit

Acyclovir 400 mg five times daily × 5 days (older regimen, more dosing burden); valacyclovir 500–1000 mg twice daily × 5–7 days for primary or more severe outbreaks; for patients with ≥6 cold sore outbreaks per year, suppressive therapy with valacyclovir 500 mg once daily or acyclovir 400 mg twice daily is effective and evidence-based per CDC and Cleveland Clinic guidance. Topical antivirals (docosanol 10%, acyclovir 5% cream) are FDA-approved OTC options but provide minimal benefit compared to oral therapy and are not recommended over oral antivirals by guidelines.

Yes — generic valacyclovir is a Tier 1–2 formulary drug on Aetna CA; typical cost $15–$35 for a 30-day supply (GoodRx as low as $18–$26 at California pharmacies). Generic acyclovir tablets are even less expensive — typically $8–$20. Topical antiviral creams (e.g., Zovirax topical) are generally OTC and not subject to the pharmacy benefit.

Per CDC STI Treatment Guidelines and multi-national clinical guidelines consensus (2024 review, Acta Odontológica Latinoamericana), nucleoside antivirals — acyclovir, valacyclovir, famciclovir — are the drugs of choice for herpes labialis. Valacyclovir is preferred over acyclovir for episodic treatment because of superior oral bioavailability and a simpler 1-day dosing regimen. Antivirals do not eradicate latent HSV-1 in trigeminal ganglia; they shorten outbreak duration and reduce viral shedding. Initiation within the prodromal phase (before vesicle formation) produces the greatest clinical benefit — patient education on recognizing prodromal symptoms is part of the visit.

Yes — Aetna CA covers generic valacyclovir for both episodic treatment and continuous suppressive therapy. Suppressive therapy (valacyclovir 500 mg daily, or 1 g daily for frequent reactivators) is appropriate for patients with ≥6 outbreaks per year, those with severe or prolonged outbreaks, or patients who want to minimize recurrences for personal or occupational reasons (e.g., public-facing roles). Dr. Bhavsar will document the clinical indication for suppressive therapy in the visit summary to support ongoing pharmacy refills. Suppressive therapy reduces outbreak frequency by approximately 70–80%.

Yes. Same-day video visits are available, and antiviral therapy has benefit even after the prodromal phase, though benefit is greatest when started in the prodrome (tingling/burning before vesicles appear). Valacyclovir 2 g twice × 1 day is FDA-approved for episodic cold sore treatment and has been shown to reduce healing time and severity when started even at the early vesicle stage. If lesions have already crusted, the outbreak is near resolution and antiviral treatment has minimal benefit — but Dr. Bhavsar can still discuss suppressive therapy to prevent future outbreaks.

Generic valacyclovir is a Tier 1–2 formulary drug on most Aetna CA commercial plans, meaning your cost-sharing is typically $5–$35 depending on your plan design and whether you've met your deductible. GoodRx prices at California pharmacies (CVS, Walgreens, Rite Aid, Costco) run $18–$29 for a 30-tablet supply — sometimes cheaper than your insurance copay. Dr. Bhavsar can send the prescription to any California pharmacy and you can compare prices at the counter.

Yes. Autoinoculation (spreading HSV-1 from the lip to the eye, finger, or genitals) is possible during active outbreaks — avoid touching lesions and wash hands thoroughly. Transmission to a partner is possible even without visible lesions due to asymptomatic viral shedding, though shedding rates are highest during active outbreaks. Suppressive valacyclovir therapy reduces (but does not eliminate) viral shedding. Herpetic keratoconjunctivitis — eye involvement — is a medical emergency requiring immediate ophthalmology evaluation; do not apply eye drops to a suspected cold sore on the eyelid without evaluation.

Yes. Aetna commercial plans cover telehealth visits for Herpes Labialis (Oral Cold Sores) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your cold sore treatment visit. Self-pay is always available for a flat $79 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $79 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your cold sore treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $79 self-pay option is also FSA/HSA eligible.